DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Estetrol is an investigational drug.
There have been 19 clinical trials for Estetrol. The most recent clinical trial was a Phase 2 trial, which was initiated on August 1st 2016.
The most common disease conditions in clinical trials are Prostatic Neoplasms, Breast Neoplasms, and Hot Flashes. The leading clinical trial sponsors are Estetra, Pantarhei Bioscience, and Pantarhei Oncology B.V.
There are ninety-two US patents protecting this investigational drug and six hundred and fifty-seven international patents.
Recent Clinical Trials for Estetrol
|Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women||ICON Clinical Research||Phase 3|
|Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women||Estetra||Phase 3|
|Effect of Food on the Bioavailability of 30 mg Estetrol (E4) Tablet in Healthy Postmenopausal Female Volunteers||Donesta Bioscience||Phase 1|
Top disease conditions for Estetrol
Top clinical trial sponsors for Estetrol
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Estetrol||See Pricing||Synthesis of estetrol via estrone derived steroids||Donesta Bioscience B.V. (Zeist, NL)||See Pricing|
|Estetrol||See Pricing||Neuroprotection and myelin repair using Nestorone.RTM.||The Population Council, Inc. (New York, NY)||See Pricing|
|Estetrol||See Pricing||Gene fusions and gene variants associated with cancer||LIFE TECHNOLOGIES CORPORATION (Carlsbad, CA)||See Pricing|
|Estetrol||See Pricing||Controlled release dosage form||TRIASTEK, INC. (Nanjing, CN)||See Pricing|
|Estetrol||See Pricing||Tablet containing dehydroepiandrosterone (DHEA)||PANTARHEI BIOSCIENCE B.V. (Zeist, NL)||See Pricing|
|Estetrol||See Pricing||Apparatus and methods for drug delivery using multiple reservoirs||CLEARSIDE BIOMEDICAL, INC. (Alpharetta, GA)||See Pricing|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|